SCHEMBL28962

SCHEMBL28962

CCCCC#P

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11599705 0.93
SCHEMBL11600152 0.90 TSHR (0.53)
SCHEMBL15157390 0.90 TSHR (0.53)
SCHEMBL11600312 0.90 TSHR (0.53)
SCHEMBL3643749 0.90 TSHR (0.53)
SCHEMBL11599083 0.90 TSHR (0.53)
SCHEMBL11601653 0.90
SCHEMBL11599301 0.90
SCHEMBL11599243 0.90 TSHR (0.53)
SCHEMBL6291054 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 548 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026273-A1 THERAPY FOR REDUCED OTOTOXICITY FROM CHEMOTHERAPEUTIC AGENT WITH PENTAAZA MACROCYCLIC RING COMPLEX GALERA LABS, LLC (US) 2024-02-01 WO claimed
CN-116019984-B Single-layer hydrophilic coating, preparation system thereof and application thereof in hydrophilic modification of medical device surface 上海发微医用材料有限公司 2023-09-19 CN claimed
CN-116672515-A Coating system comprising hydrophilic polymers, bilayer coating system, hydrophilic coating and use 上海发微医用材料有限公司 2023-09-01 CN claimed
CN-115970070-B Coating system comprising hydrophilic polymers, bilayer coating system, hydrophilic coating and use 上海发微医用材料有限公司 2023-08-18 CN claimed
US-20230218633-A1 METHODS OF TREATING ORAL MUCOSITIS GALERA LABS, LLC 2023-07-13 US claimed
CN-116390731-A Combined cancer therapy with pentaaza macrocyclic complexes and hormonal therapeutic agents 加莱拉实验室有限责任公司 2023-07-04 CN claimed
US-20230158042-A1 COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT BIOSSIL INC. (CA) 2023-05-25 US claimed
US-20230149358-A1 COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT BIOSSIL INC. (CA) 2023-05-18 US claimed
CN-116019984-A Single-layer hydrophilic coating, preparation system thereof and application thereof in hydrophilic modification of medical device surface 上海发微医用材料有限公司 2023-04-28 CN claimed
CN-115970070-A Coating system comprising hydrophilic polymers, bilayer coating system, hydrophilic coating and use 上海发微医用材料有限公司 2023-04-18 CN claimed
WO-1995028968-A1 DIAGNOSTIC IMAGE ANALYSIS WITH METAL COMPLEXES MONSANTO COMPANY (US) 1995-11-02 WO claimed
EP-0679155-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE. MONSANTO CO (US) 1995-11-02 EP claimed
EP-0616618-A1 ETHYLENE/LONGER ALPHA-OLEFIN COPOLYMERS. EXXON CHEMICAL PATENTS INC (US) 1994-09-28 EP claimed
WO-1994015925-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1994-07-21 WO claimed
EP-0598753-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1994-06-01 EP claimed
WO-1993012151-A1 ETHYLENE/LONGER ALPHA-OLEFIN COPOLYMERS EXXON CHEMICAL PATENTS INC. (US) 1993-06-24 WO claimed
WO-1993002090-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1993-02-04 WO claimed
EP-0524161-A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide MONSANTO COMPANY (US) 1993-01-20 EP claimed
US-5137857-A Polymerization process SHELL OIL COMPANY (US) 1992-08-11 US claimed
US-5030712-A Polymerization of CO/olefin with aryl phosphine sulfide SHELL OIL COMPANY (US) 1991-07-09 US claimed